He established his academic career in radiopharmaceutical chemistry and drug development at the University of Hull and Hull York Medical School. He led on the development of infrastructure for preclinical and clinical nuclear medicine, and embedded innovative translational capabilities.

He has over 25 years of research experience in medical imaging and nuclear medicine. He has identified unmet challenges in radiopharmaceutical development, production and clinical application, and addressed them through technology designed for clinical need in a format for rapid adoption.